CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324577
- Phone
- 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $389,304
- in 3 filings
Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-21 | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | Option exercise | +6,667 | 17,139 | ||
| 2022-08-21 | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −6,667 | 0 | ||
| 2022-06-14 | Gray Cameron Director | Option exercise | +61,111 | $2.70 | $165K | 738,611 |
| 2022-06-14 | Gray Cameron Director | Shares withheld for taxes | −51,562 | $3.20 | $165K | 687,049 |
| 2022-06-14 | Gray Cameron Director | Option exercise · Warrants | −61,111 | 0 | ||
| 2022-05-27 | Morich Frank Director | Purchase | +28,000 | $3.75 | $105K | 28,000 |
| 2022-05-24 | Fletcher Aaron G.L. Director | Purchase | +55,000 | $3.34 | $184K | 940,000 |
| 2022-05-23 | Fletcher Aaron G.L. Director | Purchase | +150,000 | $3.52 | $528K | 885,000 |
| 2022-03-31 | Suri Anish PRESIDENT AND CSO | Option exercise | +16,668 | 110,706 | ||
| 2022-03-31 | Suri Anish PRESIDENT AND CSO | Shares withheld for taxes | −7,068 | $4.88 | $34K | 103,638 |
| 2022-03-31 | Suri Anish PRESIDENT AND CSO | Option exercise · Restricted Stock Units | −16,668 | 0 | ||
| 2022-03-31 | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | Option exercise | +75,000 | 173,700 | ||
| 2022-03-31 | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −32,122 | $4.88 | $157K | 141,578 |
| 2022-03-31 | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | Gift | −10,000 | 131,578 | ||
| 2022-03-31 | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −75,000 | 0 | ||
| 2022-03-31 | Fletcher Aaron G.L. Director | Purchase | +735,000 | $4.76 | $3.5M | 735,000 |
| 2022-03-25 | NASSHORN PATRICIA Chief Business Officer | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2022-03-25 | Suri Anish PRESIDENT AND CSO | Grant or award · Stock Option (right to buy) | +21,333 | 21,333 | ||
| 2022-03-25 | Sandercock Colin SVP, GENERAL COUNSEL | Grant or award · Stock Option (right to buy) | +16,667 | 16,667 | ||
| 2022-03-25 | Pienta Kenneth Chief Medical Officer | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 |
Page 7 of 17 · 323 trades